■ Qingdao financial daily / home page reporter
Dou Yanfeng
The fourth industrial revolution characterized by the development of big data and artificial intelligence is affecting social transformation. In the medical field, the addition of artificial intelligence also makes medical services more humanized and intelligent. Recently, Qingdao Baiyang Intelligent Technology Co., Ltd. (hereinafter referred to as “Baiyang intelligent technology”) released its independently developed intelligent medical software and hardware all-in-one machine – Baiyang glioma intelligent all-in-one machine in Qingdao. This is the landmark achievement of Baiyang intelligent technology in the independent research and development of medical devices. It not only reflects the strong R & D strength of Baiyang intelligent technology in the field of medical device software, but also represents an important step taken by Baiyang intelligent technology in the R & D and commercialization of therapeutic medical AI imaging products.
AI can improve the accuracy of tumor treatment
China’s incidence rate of brain and nervous system tumors accounts for about 1/2 of the world. The incidence rate of gliomas is about 45% of the incidence of intracranial malignant tumors. Surgical resection is the main treatment of tumor. The accuracy and scope of resection greatly affect the survival rate of patients.
The brain glioma intelligent all-in-one machine independently developed by Baiyang intelligent technology originates from the advanced core algorithm of Harvard Medical School. After more than two years of continuous in-depth development and optimization algorithm by the team of Baiyang intelligent technology artificial intelligence research institute, and integrating more independently developed advanced technologies, it has successfully adopted the leading artificial intelligence driven cross-modal image fusion and registration technology to fuse CT and MRI images, Give full play to the advantages of multimodal images, complete fusion registration through accurate artificial intelligence technology, accurately display lesions, blood vessels, nerves and other tumors and surrounding important tissue structures, help surgeons accurately understand the overall picture of tumors, clarify the relationship between tumors and surrounding tissues, so as to formulate detailed preoperative plans, reduce surgical risks and surgical injuries, and reduce patients’ pain. At the same time, the intuitive and vivid 3D display effect can help patients easily understand the condition and operation, realize the joint decision-making of doctors and patients, and greatly improve the efficiency of clinical diagnosis and treatment and the effect of disease treatment. It is a new breakthrough in the field of therapeutic medical AI imaging products.
The whole process solution promotes the implementation of artificial intelligence
As a Innovation Medical Management Co.Ltd(002173) product independently developed by Baiyang intelligent technology, Baiyang intelligent medical all-in-one machine has independent intellectual property rights and can be deployed locally according to the characteristics of the hospital, so as to truly realize the non discharge of data, focus on the accurate diagnosis and treatment of major diseases, provide artificial intelligence auxiliary support for doctors’ decision-making, and make artificial intelligence truly used. In addition, Baiyang intelligent technology has also created a CDSS system for tumor intelligent decision-making and treatment plan, which helps doctors formulate treatment plans, and cooperates with Baiyang intelligent medical all-in-one machine to build an artificial intelligence solution throughout the whole process of tumor surgery and treatment.
At present, the artificial intelligence solution of Baiyang intelligent technology has been implemented in many hospitals. Cooperate with the top expert team of China Shenwai in the diagnosis and treatment analysis of hypertensive intracerebral hemorrhage and the construction of the whole database of hypertensive intracerebral hemorrhage to provide AI technical support for the prognosis evaluation of treatment; Combined with the expert experience of Beijing Union Medical College Hospital, explore the disease treatment of glioma and jointly improve the level of clinical diagnosis and treatment through the combination of “artificial intelligence + expert experience + guideline consensus”; Cooperate with Xuanwu Hospital to explore the use of artificial intelligence technology to help doctors carry out patient management services; We have reached intelligent teaching cooperation with Southwest Hospital of Army Medical University and Tongren Hospital to provide young doctors with more authentic and immersive learning tools.
As a medical device service provider characterized by AI, Baiyang intelligent technology and its holding subsidiaries have hundreds of independent intellectual property rights and applied for dozens of invention patents. “In the long run, the medical industry must embrace informatization and artificial intelligence, which is an indisputable trend. Based on the advantages of localization, Baiyang intelligent technology will make use of its accumulated rich experience to contribute better products, optimize and improve the clinical application level of medical artificial intelligence products, and bring China’s medical technology and services to a higher level.” Li Qin, CEO of Baiyang intelligent technology, said.
Baiyang intelligent technology is one of the scientific and technological innovation enterprises cultivated and incubated by Qingdao Baheal Medical Inc(301015) group. As a health industry resource integration platform driven by medical science and technology innovation, Baiyang has developed in three fields: innovative drugs, high-end medical devices and scientific research achievement transformation platform. As an “industrial investor”, Baiyang has provided dual support of “financial incubation + industrial incubation” for innovative enterprises, including product approval, marketing promotion, commercial insurance Corporate governance and other elements are allocated to incubate innovation with industrial resources. At present, Baiyang has formed scientific research achievements transformation cooperation with the “national team” and top scientific research institutes such as the National Heart Disease Center, the national trauma center, the Institute of systems of the Chinese Academy of Medical Sciences and Beijing Union Medical College Hospital, and has continuously formed a medical and health science and technology innovation Shenzhen New Industries Biomedical Engineering Co.Ltd(300832) cluster covering advanced technologies, products and services.
